RICERCA ITALIANA     

FIRB simili:

• 1 - Sviluppo di molecole innovative in grado di curare malattie neurodegenerative e neuroinfiammatorie.
• 2 - Misfolding di proteine e patologie umane: studio della conversione patologica di proteine globulari in aggregati fibrillari e sviluppo di farmaci che inibiscano i processi di misfolding e aggregazione
• 3 - Meccanismi molecolari della morte cellulare e loro implicazione in patologia umana
• 4 - Metabolismo e organizzazione degli sfingolipidi in modelli di neurodegenerazione cellulare: comprensione dei meccanismi molecolari di base e sviluppo di nuove strategie terapeutiche.
• 5 - Modelli transgenici per malattie ad eziologia complessa
• 6 - Riconoscimento molecolare e funzionalità cellulare
• 7 - ESPRESSIONE GENICA ED ACCUMULO DI PROTEINE D'INTERESSE AGRONOMICO NELLA CELLULA VEGETALE: MECCANISMI TRASCRIZIONALI E POST-TRASCRIZIONALI
• 8 - MECCANISMI DI DEGENERAZIONE NEURONALE
• 9 - FOLDING E AGGREGAZIONE DI PROTEINE: METALLI E BIOMOLECOLE NELLE MALATTIE CONFORMAZIONALI
• 10 - PROTEASI NELLA RISPOSTA CELLULARE NORMALE E PATOLOGICA: IDENTIFICAZIONE DEI SUBSTRATI ENDOGENI E DEI MECCANISMI MOLECOLARI INDOTTI

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze biologiche
  • BIOCHIMICA
  • BIOLOGIA MOLECOLARE
• Area scientifico disciplinare: Scienze mediche
  • NEUROLOGIA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

Classificazione geografica

• Regione: Lazio

Bibliografia

Atlante A. et al. (1998) Neuronal apoptosis in rats is accompanied by rapid impairment of cellular respiration and is prevented by scavengers of reactive oxygen species. Neurosci. Lett. 245: 127-130.

Alvarez A, et al. (2001) A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons.
Exp Cell Res 264(2):266-74.

Aridor M, Hannan LA. (2000) Traffic jam: a compendium of human diseases that affect intracellular transport processes. Traffic. 1(11):836-51

Borsello T. et al. (2000) Granule neuron DNA damage following deafferentation in adult rats cerebellar cortex: a lesion model. Neuroscience 95:163-171

Brion J et al.(1985) Mise en evidence immunologique de la protein tau au niveau des lesions de degenerescence neurofibrillaire dela maladie D'Alzheimer. Arch Biol 95: 229-235, 1985.

Canu N. et al. (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18: 7061-7074

Canu N., et al. (2000) Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis. J. Neurosci., 20: 589-599

Capsoni S et al. (2000) Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci U S A 97(12):6826-31

De Berardinis et al. (2001) Transfer of the apoptotic message in sister cultures of cerebellar neurons. Neuroreport 12: 2137-2140.

Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56: 321-339.

D'Mello et al. (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-growth factor I and cAMP. Proc Natl Acad Sci U S A 90: 10989-10993.

Galli C. et al. (1995) Apoptosis in cerebellar granule cells is blocked by high KCI, Forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J. Neurosci. 15: 1172-1179.

Galli C. et al. (1998) Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis. P.N.A.S. USA, 95:1247-1252

Games D et al. (1995) Alzheimer-type neuropathology in transgenic mice overespressing V717beta-amyloid precursor protein. Nature 373: 532-527.

Gething MJ, Sambrook J. (1992) Protein folding in the cell. Nature. 2;355(6355):33-45.

Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 2001 293 :1491-5.

Grundke-Iqbal I et al. (1986) Abnormal phosphorylation of the microtubule-associated protein t (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83: 4913-4917.

Gurney ME et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation (1994) Science 264:1772-1775

Haass C et al. (1992) Amyloid -peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325,

Hsiao KK et al. (1990). Spontaneus neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587-90.

Kim PS, Arvan P. (1998) Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev 19(2):173-202.

Kopito RR, Sitia R. (2000) Aggresomes and Russell bodies. Symptoms of cellular indigestion? EMBO Rep. 1(3):225-31.

Kosik KS et al. (1986) Microtubule-associated protein, tau, is a major antigenic component of paired helical filaments in Alzheimer's disease. Proc Natl Acad Sci USA 83:
4044-4048.

Jarrett JT et al. (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32: 4693-4697.

Jellinger KA, Stadelmann C. (2000) Mechanisms of cell death in neurodegenerative disorders. J Neural Transm Suppl. 59:95-114.

Liu H et al. (1999) .Solution structure of Syrian hamster prion protein rPrP(90-231). Bio chemistry;38:5362-77.

Pan KM, et al. (1993) Conversion of a -helices int b -sheets features in the formation of the scrapie prion proteins.Pr c Natl Acad Sci U S A 90:10962-6

Patrick GN, et al. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature.

Perez RG, et al. (1999) Mutagenesis identifies new signals for -amyloid precursor protein endotycosis, turnover and the generation of secreted fragments, including A42. J Biol Chem 274: 18851-18856

Piccini et al. (2000) Endogenous derivatives oppositely modulate apoptosis through an autocrin loop. Neuroreport 11: 1375-1379.

Prusiner SB (1984) .Some speculations about prions ,amyloid ,and Alzheimer ’s dis- ease.N Engl J Med;310:661-3.

Prusiner SB (1991) Molecular biology of prion diseases. Science 252: 1515-22.

Prusiner SB (1998).Prions.Pr c Natl Acad Sci U S A;95:13363-83.

Prusiner SB.Development of the prion concept (1999) .In:Prusiner SB,ed. Prion biology and diseases.Cold Spring Harb r,N.Y.:ColdSpring Harbor Laborat ry Press :67-112.

Perlmutter DH. (1999) Misfolded proteins in the endoplasmic reticulum. Lab Invest. 79(6):623-38

Prusiner SB. (2001) Shattuck lecture--neurodegenerative diseases and prions. N Engl J Med. 17;344(20):1516-26.

Riek R, et al. (1996) NMR structure of the mouse prion protein domain PrP(121- 231). Nature;382:180-2.

Safar J, et al. (1984) Eight prion strains have PrP Sc molecules with different conformations. Nat Med 4:1157-65.

Selkoe DJ, et al. (1988) -Amyloid precursor protein of Alzheimer disease occurs as 110-135 kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci USA 85: 7341-7345

Seubert P, et al. (1993) Secretion of betaamyloid precursor protein cleaved at the amino-terminus of the -amyloid peptide. Nature 361: 260-263.

Sherman MY, Goldberg AL. (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29(1):15-32

Sifers RN. (1995) Defective protein folding as a cause of disease. Nat Struct Biol.;2(5):355-7.

Sinha S, et al. (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402: 537-540.

Sisodia SS, et al. (1990) Evidence that -amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-495.

Stadelmann C et al. (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol. 155(5):1459-66.

Takashima A, et al. (2001) Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain. Neurosci Lett. 22;306

Troy CM, et al. (2001) beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J Neurochem. 77(1):157-64.

Parole Chiave

Modelli animali e cellulari di malattie neurodegenerative; proteina precursore dell'amiloide (APP); Proteina TAU; Anticorpi intracellulari; Apoptosi; Neurotrofine